当前位置： SCI文献检索 > NeuroImage-Clinical期刊下所有文献 > High-resolution metabolic imaging of high-grade gliomas using 7T-CRT-FID-MRSI.

High-resolution metabolic imaging of high-grade gliomas using 7T-CRT-FID-MRSI.

Abstract：

OBJECTIVES:Successful neurosurgical intervention in gliomas depends on the precision of the preoperative definition of the tumor and its margins since a safe maximum resection translates into a better patient outcome. Metabolic high-resolution imaging might result in improved presurgical tumor characterization, and thus optimized glioma resection. To this end, we validated the performance of a fast high-resolution whole-brain 3D-magnetic resonance spectroscopic imaging (MRSI) method at 7T in a patient cohort of 23 high-grade gliomas (HGG). MATERIALS AND METHODS:We preoperatively measured 23 patients with histologically verified HGGs (17 male, 8 female, age 53 ± 15) with an MRSI sequence based on concentric ring trajectories with a 64 × 64 × 39 measurement matrix, and a 3.4 × 3.4 × 3.4 mm3 nominal voxel volume in 15 min. Quantification used a basis-set of 17 components including N-acetyl-aspartate (NAA), total choline (tCho), total creatine (tCr), glutamate (Glu), glutamine (Gln), glycine (Gly) and 2-hydroxyglutarate (2HG). The resultant metabolic images were evaluated for their reliability as well as their quality and compared to spatially segmented tumor regions-of-interest (necrosis, contrast-enhanced, non-contrast enhanced + edema, peritumoral) based on clinical data and also compared to histopathology (e.g., grade, IDH-status). RESULTS:Eighteen of the patient measurements were considered usable. In these patients, ten metabolites were quantified with acceptable quality. Gln, Gly, and tCho were increased and NAA and tCr decreased in nearly all tumor regions, with other metabolites such as serine, showing mixed trends. Overall, there was a reliable characterization of metabolic tumor areas. We also found heterogeneity in the metabolic images often continued into the peritumoral region. While 2HG could not be satisfyingly quantified, we found an increase of Glu in the contrast-enhancing region of IDH-wildtype HGGs and a decrease of Glu in IDH1-mutant HGGs. CONCLUSIONS:We successfully demonstrated high-resolution 7T 3D-MRSI in HGG patients, showing metabolic differences between tumor regions and peritumoral tissue for multiple metabolites. Increases of tCho, Gln (related to tumor metabolism), Gly (related to tumor proliferation), as well as decreases in NAA, tCr, and others, corresponded very well to clinical tumor segmentation, but were more heterogeneous and often extended into the peritumoral region.

journal_name

Neuroimage Clin

journal_title

NeuroImage. Clinical

authors

Hangel G,Cadrien C,Lazen P,Furtner J,Lipka A,Hečková E,Hingerl L,Motyka S,Gruber S,Strasser B,Kiesel B,Mischkulnig M,Preusser M,Roetzer T,Wöhrer A,Widhalm G,Rössler K,Trattnig S,Bogner W

doi

10.1016/j.nicl.2020.102433

subject

Has Abstract

pub_date

2020-01-01 00:00:00

pages

102433

issn

2213-1582

pii

S2213-1582(20)30270-9

journal_volume

pub_type

杂志文章

在线工具

High-resolution metabolic imaging of high-grade gliomas using 7T-CRT-FID-MRSI.